"Acitretin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
| Descriptor ID |
D017255
|
| MeSH Number(s) |
D02.455.326.271.665.202.495.050 D02.455.849.131.495.050 D23.767.261.700.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acitretin".
Below are MeSH descriptors whose meaning is more specific than "Acitretin".
This graph shows the total number of publications written about "Acitretin" by people in this website by year, and whether "Acitretin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acitretin" by people in Profiles.
-
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020 Jun; 82(6):1445-1486.
-
Photolichenoid plaques with associated vitiliginous pigmentary changes. Dermatol Online J. 2011 Oct 15; 17(10):13.
-
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May; 58(5):826-50.
-
Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf. 2002; 25(13):913-27.